These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 510506)

  • 21. Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD
    Isr J Med Sci; 1979 Jan; 15(1):9-11. PubMed ID: 422345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of leukocyte migration by extracts of malignant prostatic tissue and correlation of degree of in vitro sensitization to clinical responsiveness in prostatic cancer patients.
    Ablin RJ; Bush IM; Bruns GR; John T; Sadoughi N; Guinan PD
    Urology; 1978 Mar; 11(3):289-92. PubMed ID: 565097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.
    Bhatti R; Shaw M; Ray P
    Experientia; 1987 Aug; 43(8):916-7. PubMed ID: 3622734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic aspects of malignancy. II. Host immunocompetence and relationship to the clinical stage in patients with prostatic cancer.
    Ablin RJ; Guinan PD; Rios ER
    Allergol Immunopathol (Madr); 1976; 4(4):247-54. PubMed ID: 983900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD; Khin W
    Clin Exp Immunol; 1979 Oct; 38(1):83-91. PubMed ID: 93529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Dunning R3327 prostate adenocarcinoma in the Fischer-Copenhagen F1 rat: a useful model for immunological studies.
    Claflin AJ; McKinney EC; Fletcher MA
    Oncology; 1977; 34(3):105-9. PubMed ID: 917439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum proteins in prostatic cancer VI. Reduction of the suppressive ("blocking"?) properties of serum on in vitro parameters of cell-mediated immunologic responsiveness following cryosurgery.
    Ablin RJ
    Urol Int; 1977; 32(1):65-73. PubMed ID: 70099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro studies in reproductive immunology. 1. Suppression of cell-mediated immune response by human spermatozoa and fractions isolated from human seminal plasma.
    Marcus ZH; Freisheim JH; Houk JL; Herman JH; Hess EV
    Clin Immunol Immunopathol; 1978 Mar; 9(3):318-26. PubMed ID: 564250
    [No Abstract]   [Full Text] [Related]  

  • 29. "Immunostaging" of patients with prostatic cancer: correlation of "immunostage" and clinical stage. An interim report.
    Ablin RJ; Guinan PD; Sundar B; Bush IM
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):674-9. PubMed ID: 825353
    [No Abstract]   [Full Text] [Related]  

  • 30. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
    Averna TA; Kline EE; Smith AY; Sillerud LO
    J Urol; 2005 Feb; 173(2):433-8. PubMed ID: 15643195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.
    Nadji M; Tabei SZ; Castro A; Chu TM; Murphy GP; Wang MC; Morales AR
    Cancer; 1981 Sep; 48(5):1229-32. PubMed ID: 6168364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Humoral and cellular immunity in prostatic adenocarcinoma].
    Pérez Herrero F; Alfonso Sánchez M; Gutierrez Mínguez E; Urrutia Avisrror M; Montero Gómez J
    Actas Urol Esp; 1983; 7(6):433-6. PubMed ID: 6670612
    [No Abstract]   [Full Text] [Related]  

  • 34. Equine seminal plasma reduces sperm binding to polymorphonuclear neutrophils (PMNs) and improves the fertility of fresh semen inseminated into inflamed uteri.
    Alghamdi AS; Foster DN; Troedsson MH
    Reproduction; 2004 May; 127(5):593-600. PubMed ID: 15129015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Endometrial' adenocarcinoma of the prostatic urethra arising in a villous polyp. A light microscopic and immunoperoxidase study.
    Walker AN; Mills SE; Fechner RE; Perry JM
    Arch Pathol Lab Med; 1982 Nov; 106(12):624-7. PubMed ID: 6182857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate.
    Bhatti RA; Ablin RJ; Condoulis W; Guinan PD
    Cancer Res; 1979 Sep; 39(9):3328-31. PubMed ID: 476662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy.
    Eskandari H; Ablin RJ; Bhatti RA
    Indian J Exp Biol; 1982 Dec; 20(12):872-4. PubMed ID: 7183523
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostate-specific antigen in adenocarcinoma of the prostate.
    N Engl J Med; 1988 Apr; 318(15):992-3. PubMed ID: 2451131
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunologic studies of prostatic cancer using the R3327 rat model.
    Lubaroff DM; Reynolds CW; Culp DA
    Trans Am Assoc Genitourin Surg; 1978; 70():60-5. PubMed ID: 753024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors].
    Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M
    Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.